Aspartate aminotransferase‑to‑platelet ratio index (APRI) reliably excludes advanced fibrosis and cirrhosis in treated autoimmune hepatitis
APRI is a simple, non-invasive, widely applicable score that reliably excludes advanced fibrosis (≥F3 on TE) and cirrhosis (F4 on TE) during AIH treatment, potentially reducing the need for additional investigations.
Authors
- Maaike Biewenga (ORCID: https://orcid.org/0000-0002-2797-6164)
- Maarten E. Tushuizen (ORCID: https://orcid.org/0000-0001-6342-9056)
- Albert Friedrich Stättermayer (ORCID: https://orcid.org/0000-0003-0737-4091)
- Bart van Hoek (ORCID: https://orcid.org/0000-0001-6527-764X)
- Martine A.M.C. Baven-Pronk
- Camiel J M Marijnissen
Institutions
- Leiden University Medical Center (NL)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1016/j.aohep.2025.102146
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 0.00